Stay updated on Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial
Sign up to get notified when there's something new on the Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial page.

Latest updates to the Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0. No user-facing content on the study page appears to be affected.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe site revision has been updated to v3.5.0, replacing v3.4.3.SummaryDifference0.1%

- Check39 days agoChange DetectedPage revision label updated from Revision: v3.4.2 to Revision: v3.4.3.SummaryDifference0.1%

- Check67 days agoChange DetectedThe webpage shows an addition of Revision: v3.4.2 and the removal of the prior government funding notice (Revision: v3.4.1). These changes do not affect the study details, inclusion criteria, or outcome measures for NCT02632747; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedIncorporated a site-wide notice about a lapse in government funding and updated the revision tag to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedGlossary toggle added; footer metadata updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', with capitalization tweaks to 'No FEAR Act Data'. These edits are cosmetic and metadata-related, not affecting study content, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial page.